Takeda Pharmaceutical Co ADR (NYSE: TAK) is -2.87% lower on its value in year-to-date trading and has touched a low of $12.57 and a high of $15.08 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TAK stock was last observed hovering at around $13.79 in the last trading session, with the day’s gains setting it 0.07%.
Currently trading at $13.86, the stock is -1.01% and -3.75% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.04 million and changing 0.51% at the moment leaves the stock -0.55% off its SMA200. TAK registered 0.58% gain for a year compared to 6-month gain of 3.66%. The firm has a 50-day simple moving average (SMA 50) of $14.4218 and a 200-day simple moving average (SMA200) of $13.94115.
The stock witnessed a -2.94% loss in the last 1 month and extending the period to 3 months gives it a -0.07%, and is -0.57% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.25% over the week and 1.14% over the month.
Takeda Pharmaceutical Co ADR (TAK) has around 49281 employees, a market worth around $43.94B and $30.22B in sales. Current P/E ratio is 22.99 and Fwd P/E is 28.47. Profit margin for the company is 6.36%. Distance from 52-week low is 10.22% and -8.09% from its 52-week high. The company has generated returns on investments over the last 12 months (2.42%).
The EPS is expected to shrink by -9.00% this year
345.0 institutions hold shares in Takeda Pharmaceutical Co ADR (TAK), with institutional investors hold 2.24% of the company’s shares. The shares outstanding are 3.17B, and float is at 3.17B with Short Float at 0.23%. Institutions hold 2.24% of the Float.
The top institutional shareholder in the company is CAPITAL RESEARCH GLOBAL INVESTORS with over 13.13 million shares valued at $169.86 million. The investor’s holdings represent 0.8366 of the TAK Shares outstanding. As of 2024-06-30, the second largest holder is MONDRIAN INVESTMENT PARTNERS LTD with 7.74 million shares valued at $108.34 million to account for 0.4932 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 4.99 million shares representing 0.3178 and valued at over $64.53 million, while MILLENNIUM MANAGEMENT LLC holds 0.277 of the shares totaling 4.35 million with a market value of $56.24 million.
Takeda Pharmaceutical Co ADR (TAK) Insider Activity
Takeda Pharmaceutical Co ADR disclosed in a document filed with the SEC on Jan 24 ’24 that TAKEDA PHARMACEUTICAL CO LTD (10% Owner) sold a total of 3,703,703 shares of the company’s common stock. The trade occurred on Jan 24 ’24 and was made at $8.10 per share for $30.0 million. Following the transaction, the insider now directly holds 3.76 million shares of the TAK stock.
